Search
Suxibuzone
go.drugbank.com/drugs/DB13232ExperimentalCategories: Topical Products for Joint and Muscular Pain, Antiinflammatory Preparations, Non-Steroids for Topical UseDesmethylprodine
go.drugbank.com/drugs/DB01478ExperimentalIllicitIt is known to be a designer drug, synthesized in 1977, for the purpose of recreational use. Illicit manufacturing has occurred.
SYNB1353
go.drugbank.com/drugs/DB17666Investigational[A258833] Developed by Synlogic Operating Company, Inc., SYNB1353 is being investigated for the treatment of homocystinuria.
Triflusal
go.drugbank.com/drugs/DB08814ApprovedWithdrawnUriach and Company and even though it is commercialized in different countries it is not approved by the FDA, EMA or HealthCanada.
D-Cysteine
go.drugbank.com/drugs/DB03201ExperimentalA thiol-containing non-essential amino acid that is oxidized to form CYSTINE.
Carboxin
go.drugbank.com/drugs/DB04657ApprovedWithdrawnA systemic agricultural fungicide and seed treatment agent.
Categories: Compounds used in a research, industrial, or household settingEsuprone
go.drugbank.com/drugs/DB20862ExperimentalEsuprone is a small molecule drug. Esuprone has a monoisotopic molecular weight of 282.06 Da.
Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesVA-MENGOC-BC®
go.drugbank.com/drugs/DB15800ExperimentalAs of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials. … As there already exists a polysaccharide-based vaccine against meningococcal disease originating from serogroups A,C,W135, and Y, this vaccine was created for use against serogroups B and C.